Schneyer Mark C. sold ACAD
August 6, 2026 · Form 4 insider transaction
Schneyer Mark C. sold 9,292 shares of ACADIA Pharmaceuticals Inc. at $29.34 per share, a transaction worth $272.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
9,292
Price
$29.34
Total value
$272.6K
InsiderSchneyer Mark C.
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 6, 2026
Filing dateAugust 7, 2026
Shares owned after67,828
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 19, 2025.